Abstract
Background: H2S is the third gas transmitter affecting the growth, reproduction and survival of cancer cells. However, the H2S anticancer and antitumor mechanism still needs to be further studied. Methods: Here, FHS-1 was synthesized utilizing excited-state intramolecular proton transfer to detect H2S in MCF-7 cells, and investigated the effects of varying concentrations NaHS on apoptosis. Results: The study found that FHS-1 detects H2S levels with high selectivity and pH stability and that H2S may regulate apoptosis in MCF-7 cells through the p53/mTOR/STAT3 pathway. Conclusion: Researching the influence of H2S on apoptosis can serve as a theoretical foundation for future research into H2S-related anticancer medicines, and the H2S probe can be used as an effective cancer screening tool.
Graphical abstract
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Preventative therapies for healthy women at high risk of breast cancer. Cancer Manag. Res. 6, 423–430 (2014).
- 2. . Wilms tumor and breast cancer. Cancer 121(12), 2099 (2015).
- 3. . Role of STAT3 signaling pathway in breast cancer. Cell Commun. Signal. 18, 33 (2020).
- 4. Exercise training ameliorates early diabetic kidney injury by regulating the H2S/SIRT1/p53 pathway. FASEB J. 35(9), e21823 (2021).
- 5. Role of hydrogen sulfide donors in cancer development and progression. Int. J. Biol. Sci. 17(1), 73–88 (2021).
- 6. . Gasotransmitters in cancer: from pathophysiology to experimental therapy. Nat. Rev. Drug Discov. 15(3), 185–203 (2016). •• Discusses the role of each gasotransmitter in cancer and the effects of pharmacological agents (some of which are in early-stage clinical studies) that modulate levels of each gasotransmitter.
- 7. Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance. Br. J. Pharmacol. 171(18), 4322–4336 (2014).
- 8. NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS. Biochem. Pharmacol. 176, 113857 (2020).
- 9. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin. Cancer Biol. 60, 14–27 (2020).
- 10. ADT-OH, a hydrogen sulfide-releasing donor, induces apoptosis and inhibits the development of melanoma in vivo by upregulating FADD. Cell Death Dis. 11(1), 33 (2020).
- 11. Exogenous hydrogen sulfide exhibits anti-cancer effects though p38/MAPK signaling pathway in C6 glioma cells. Biol. Chem. 396(11), 1247–1253 (2015).
- 12. . The hidden role of hydrogen sulfide metabolism in cancer. Int. J. Mol. Sci. 22(12), 6562 (2021).
- 13. Exogenous hydrogen sulfide regulates the growth of human thyroid carcinoma cells. Oxid. Med. Cell. Longev. 2019, 6927298 (2019).
- 14. Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/Bcl-2 signaling pathway. Med. Oncol. 32(2), 352 (2015).
- 15. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/Bcl-2/survivin pathway. Int. J. Clin. Exp. Pathol. 8(5), 5017–5025 (2015).
- 16. Selective detection of endogenous H2S in living cells and the mouse hippocampus using a ratiometric fluorescent probe. Sci. Rep. 4, 5870 (2014).
- 17. A fluorescence turn-on probe for hydrogen sulfide and biothiols based on PET & TICT and its imaging in HeLa cells. Spectrochim. Acta A Mol. Biomol. Spectrosc. 244, 118839 (2021).
- 18. A fluorescent probe based on tetrahydro[5]helicene derivative with large Stokes shift for rapid and highly selective recognition of hydrogen sulfide. Spectrochim. Acta A Mol. Biomol. Spectrosc. 214, 487–495 (2019).
- 19. Nature of fast relaxation processes and spectroscopy of a membrane-active peptide modified with fluorescent amino acid exhibiting excited state intramolecular proton transfer and efficient stimulated emission. ACS Omega 6(15), 10119–10128 (2021).
- 20. Effects of multibranching on 3-hydroxyflavone-based chromophores and the excited-state intramolecular proton transfer dynamics. J. Phys. Chem. A 114(38), 10412–10420 (2010).
- 21. . A highly selective and sensitive 3-hydroxyflavone-based colorimetric and fluorescent probe for hydrogen sulfide with a large Stokes shift. Tetrahedron 72(24), 3531–3534 (2016).
- 22. Excited state intramolecular proton transfer (ESIPT) luminescence mechanism for 4-N,N-diethylamino-3-hydroxyflavone in propylene carbonate, acetonitrile and the mixed solvents. Spectrochim. Acta A Mol. Biomol. Spectrosc. 224, 117416 (2020).
- 23. Solvent tuning of photochemistry upon excited-state symmetry breaking. Nat. Commun. 11(1), 1925 (2020).
- 24. Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents. Chem. Soc. Rev. 47(23), 8842–8880 (2018).
- 25. Application of 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole in analysis: fluorescent dyes and unexpected reaction with tertiary amines. Anal. Biochem. 486, 5–13 (2015).
- 26. A fast-response red shifted fluorescent probe for detection of H2S in living cells. Molecules 25(3), 437 (2020).
- 27. . Emerging analytical tools for the detection of the third gasotransmitter H2S, a comprehensive review. J. Adv. Res. 27, 137–153 (2020).
- 28. . Facile syntheses of 3-hydroxyflavones. Org. Lett. 14(6), 1576–1579 (2012).
- 29. A highly selective and sensitive near-infrared fluorescent probe for imaging of hydrogen sulphide in living cells and mice. Sci. Rep. 6, 18868 (2016).
- 30. Cooperation of ESIPT and ICT processes in the designed 2-(2′-hydroxyphenyl) benzothiazole derivative: a near-infrared two-photon fluorescent probe with a large Stokes shift for the detection of cysteine and its application in biological environments. Anal. Chem. 92(20), 14236–14243 (2020).
- 31. Hydrogen sulfide ameliorates high glucose-induced pro-inflammation factors in HT-22 cells: involvement of SIRT1-mTOR/NF-κB signaling pathway. Int. Immunopharmacol. 95, 107545 (2021). • Previous studies have shown that exogenous H2S treatment or enhancement of endogenous H2S synthesis can prevent neuronal inflammation under high glucose exposure.
- 32. Fitzmaurice C, The global burden of cancer 2013. JAMA Oncol. 1(4), 505–527 (2015).
- 33. . Chemical biology of H2S signaling through persulfidation. Chem. Rev. 118(3), 1253–1337 (2018).
- 34. . Potential alteration of tumor microenvironments by β-mercaptoethanol. Future Oncol. 17(3), 315–331 (2021).
- 35. . BODIPY-based azamacrocyclic ensemble for selective fluorescence detection and quantification of homocysteine in biological applications. Biosens. Bioelectron. 72, 1–9 (2015).
- 36. . Reaction-based fluorescent probe for selective discrimination of thiophenols over aliphaticthiols and its application in water samples. Anal. Chem. 84(11), 4915–4920 (2012).
- 37. . Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression. Mol. Med. Rep. 10(1), 341–346 (2014).
- 38. . Hydrogen sulfide and cancer. Handb. Exp. Pharmacol. 230, 233–241 (2015).
- 39. Exogenous hydrogen sulfide donor NaHS alleviates nickel-induced epithelial-mesenchymal transition and the migration of A549 cells by regulating TGF-β1/Smad2/Smad3 signaling. Ecotoxicol. Environ. Saf. 195, 110464 (2020).
- 40. Hydrogen sulfide and its donors: novel antitumor and antimetastatic therapies for triple-negative breast cancer. Redox Biol. 34, 101564 (2020).
- 41. . The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer. Antioxid. Redox Signal. 22(5), 424–448 (2015).
- 42. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget 6(35), 37367–37384 (2015).
- 43. ADT-OH inhibits malignant melanoma metastasis in mice via suppressing CSE/CBS and FAK/paxillin signaling pathway. Acta Pharmacol. Sin.
doi:10.1038/s41401-021-00799-x (2021) (Epub ahead of print). - 44. New possible silver lining for pancreatic cancer therapy: hydrogen sulfide and its donors. Acta Pharm. Sin. B 11(5), 1148–1157 (2021).
- 45. . International Union of Basic and Clinical Pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors. Pharmacol. Rev. 69(4), 497–564 (2017).
- 46. Targeting hydrogen sulphide signaling in breast cancer. J. Adv. Res. 27, 177–190 (2020).
- 47. . Molecular mechanism of crocin induced caspase mediated MCF-7 cell death: in vivo toxicity profiling and ex vivo macrophage activation. Asian Pac. J. Cancer Prev. 17(3), 1499–1506 (2016).
- 48. Aged garlic extract and its constituent, S-allyl-L-cysteine, induce the apoptosis of neuroblastoma cancer cells due to mitochondrial membrane depolarization. Exp. Ther. Med. 19(2), 1511–1521 (2020).
- 49. Andrographolide induces noxa-dependent apoptosis by transactivating ATF4 in human lung adenocarcinoma cells. Front. Pharmacol. 12, 680589 (2021).
- 50. . Slugging it out: fine tuning the p53-PUMA death connection. Cell 123(4), 545–548 (2005).
- 51. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123(4), 641–653 (2005).
- 52. Paris saponin-induced autophagy promotes breast cancer cell apoptosis via the Akt/mTOR signaling pathway. Chem. Biol. Interact. 264, 1–9 (2017).
- 53. Inhibition of ROS production, autophagy or apoptosis signaling reversed the anticancer properties of Antrodia salmonea in triple-negative breast cancer (MDA-MB-231) cells. Food Chem. Toxicol. 103, 1–17 (2017). • Evaluated the combined effect of ADT-OH treatment and FADD overexpression on melanoma cell death in vivo using a mouse xenograft model and found that tumor-specific delivery of FADD through a recombinant Salmonella strain (VNP-FADD) combined with low-dose ADT-OH treatment significantly inhibited tumor growth and induced cancer cell apoptosis.
- 54. PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. Int. J. Mol. Sci. 22(1), 173 (2020).
- 55. Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. Cancer Res. 68, 8661–8666 (2008).